Literature DB >> 19533131

Immune cell-mediated liver injury.

Nadia Corazza1, Anastasia Badmann, Christoph Lauer.   

Abstract

Liver diseases represent an important cause of morbidity and mortality in the world. Death of hepatocytes and other hepatic cell types is a characteristic feature of several forms of liver injury such as cholestasis, viral hepatitis, drug- or toxin-induced injury, and alcohol-induced liver damage. Moreover, irrespectively of the reason, liver injury seems to be facilitated by similar immune effector mechanisms common to these various liver diseases. Indeed, common immune effector mechanisms may explain the high prevalence of cirrhosis and cancer development in most forms of liver disease. Improved understanding of the immune cell-mediated mechanisms involved in hepatocyte cell death could be beneficial for the development of common therapeutic strategies against different forms of liver diseases. In this review, we will discuss novel findings on the role of different immune cells in liver disease and immune cell-induced death executioner mechanisms involved in hepatocyte cell death.

Entities:  

Mesh:

Year:  2009        PMID: 19533131     DOI: 10.1007/s00281-009-0168-1

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  93 in total

Review 1.  Involvement of the liver in the induction of CD8 T cell tolerance towards oral antigen.

Authors:  P A Knolle
Journal:  Z Gastroenterol       Date:  2006-01       Impact factor: 2.000

2.  Serum levels of soluble Fas antigen in chronic hepatitis C patients.

Authors:  S Iio; N Hayashi; E Mita; K Ueda; K Mochizuki; N Hiramatsu; T Kanto; Y Sasaki; A Kasahara; M Hori
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

3.  5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.

Authors:  S Fulda; K-M Debatin
Journal:  Oncogene       Date:  2006-04-10       Impact factor: 9.867

Review 4.  TNF receptor subtype signalling: differences and cellular consequences.

Authors:  David J MacEwan
Journal:  Cell Signal       Date:  2002-06       Impact factor: 4.315

5.  Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.

Authors:  F Gantner; M Leist; A W Lohse; P G Germann; G Tiegs
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

6.  Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.

Authors:  P Costelli; P Aoki; B Zingaro; N Carbó; P Reffo; F J Lopez-Soriano; G Bonelli; J M Argilés; F M Baccino
Journal:  Cell Death Differ       Date:  2003-09       Impact factor: 15.828

7.  Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase.

Authors:  Eric L Marderstein; Brian Bucher; Zhong Guo; Xuesheng Feng; Kaye Reid; David A Geller
Journal:  Surgery       Date:  2003-08       Impact factor: 3.982

Review 8.  Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.

Authors:  Johannes G Bode; Erwin D Brenndörfer; Dieter Häussinger
Journal:  Biol Chem       Date:  2008-10       Impact factor: 3.915

9.  Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.

Authors:  Y Yamada; E M Webber; I Kirillova; J J Peschon; N Fausto
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  6 in total

1.  Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma.

Authors:  Eugene Sokolov; David A Iannitti; Laura W Schrum; Iain H McKillop
Journal:  Cell Signal       Date:  2011-05-18       Impact factor: 4.315

2.  Conjugated bilirubin affects cytokine profiles in hepatitis A virus infection by modulating function of signal transducer and activator of transcription factors.

Authors:  Flor P Castro-García; Karla F Corral-Jara; Griselda Escobedo-Melendez; Monserrat A Sandoval-Hernandez; Yvonne Rosenstein; Sonia Roman; Arturo Panduro; Nora A Fierro
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

3.  Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.

Authors:  Tobias Eggert; José Medina-Echeverz; Tamar Kapanadze; Michael J Kruhlak; Firouzeh Korangy; Tim F Greten
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 4.  Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance.

Authors:  Hilal Ahmad Khan; Muhammad Zishan Ahmad; Junaid Ali Khan; Muhammad Imran Arshad
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2017-06

5.  Efficacy and safety of spleen aminopeptide oral lyophilized powder in ameliorating liver injury in infants and children with human cytomegalovirus infection: a single-center study in China.

Authors:  Yanling Wu; Xueting Dong; Runqiu Wu; Xinguo Zheng; Yu Jin; Hui Yang
Journal:  Transl Pediatr       Date:  2021-01

6.  Continuous Activation of Dopamine Receptors Alleviates LPS-Induced Liver Injury in Mice via β-arrestin2 Dependent Akt/NF-κB Pathway.

Authors:  Mingan Li; Ce Zhang; Lin Zhou; Xiaohui Sun; Tian Wang; Fenghua Fu
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.